1,865 results on '"Karakiewicz, Pierre"'
Search Results
2. Access to trimodal therapy in muscle-invasive bladder cancer is lower in unmarried females
3. Critical care therapy use after radical cystectomy in patients with non-metastatic bladder cancer
4. Preoperative plasma insulin-like growth factor-I and its binding proteins-based risk stratification of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma
5. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients
6. Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma
7. PD23-06 SURVIVAL DIFFERENCES BETWEEN PHEOCHROMOCYTOMA AND PARAGANGLIOMA PATIENTS
8. PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA
9. MP14-10 IDENTIFYING THE OPTIMAL CANDIDATE FOR CONCOMITANT ANDROGEN-DEPRIVATION THERAPY AMONG PATIENTS RECEIVING METASTASIS-DIRECTED THERAPY FOR POSITIVE PSMA PET AND PRIMARY OR SECONDARY BIOCHEMICAL RECURRENCE FROM PROSTATE CANCER
10. MP14-13 EXPLORING THE INTERACTION BETWEEN THE USE OF METASTASIS DIRECTED THERAPY IN PATIENTS WITH POSITIVE PSMA PET AND PATTERNS OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. RESULTS OF A LARGE, SINGLE INSTITUTION SERIES
11. PD23-07 PROGNOSTIC SIGNIFICANCE OF LYMPH NODE COUNT IN SURGICALLY TREATED PATIENTS WITH T 2-4 STAGE NON-METASTATIC ADRENOCORTICAL CARCINOMA
12. MP01-01 INCREMENTAL DOSE-RESPONSE EFFECT OF AGE ON MORTALITY IN NON-SEMINOMA TESTIS CANCER PATIENTS
13. MP14-11 THE ADDED VALUE OF CONCOMITANT WHOLE-PELVIS SALVAGE RADIATION THERAPY IN OLIGO-RECURRENT PROSTATE CANCER PATIENTS TREATED WITH METASTASIS-DIRECTED THERAPY FOR DISTANT POSITIVE UPTAKES AT PSMA PET
14. MP38-16 SURVIVAL BENEFIT OF NEPHROURETERECTOMY IN SYSTEMIC THERAPY EXPOSED METASTATIC UPPER TRACT URINARY UROTHELIAL CARCINOMA PATIENTS
15. MP22-07 CONTEMPORARY CONDITIONAL CANCER-SPECIFIC SURVIVAL RATES IN SURGICALLY TREATED NON-METASTATIC PRIMARY URETHRAL CARCINOMA
16. Temporal trends and cancer-specific mortality in non-metastatic muscle-invasive urothelial carcinoma of the urinary bladder treated with trimodal therapy
17. MP58-02 ORGAN-CONFINED PT2 ISUP4/5 VS. NON-ORGAN CONFINED ≥PT3 ISUP2/3 PROSTATE CANCER: DIFFERENCES IN BIOCHEMICAL RECURRENCE-FREE SURVIVAL AND METASTASIS-FREE SURVIVAL AFTER RADICAL PROSTATECTOMY
18. MP08-11 IMPACT OF PRE-SURGERY EGFR AND HER2 PLASMA LEVELS ON POST-SURGICAL OUTCOMES IN BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY
19. MP44-03 THE IMPACT OF ISCHEMIA TIME ON RENAL FUNCTION IN PATIENTS WITH MICROCIRCULATION IMPAIRMENT DURING PARTIAL NEPHRECTOMY FOR RCC
20. MP37-20 THE EFFECT OF PENILE REHABILITATION AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY ON URINARY CONTINENCE AND ERECTILE FUNCTION RECOVERY. RESULTS FROM a HIGH-VOLUME, SINGLE-SURGEON SERIES
21. First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy
22. Contemporary conditional cancer‐specific survival rates in surgically treated nonmetastatic primary urethral carcinoma
23. Prognostic significance of lymph node count in surgically treated patients with T2-4 stage nonmetastatic adrenocortical carcinoma
24. The State of Intermediate Clinical Endpoints as Surrogates for Overall Survival in Prostate Cancer in 2024
25. Unmarried status effect on stage at presentation and treatment patterns in non-metastatic upper tract urothelial carcinoma patients
26. Survival differences in non-seminoma testis cancer patients according to race/ethnicity
27. Use of inpatient palliative care in metastatic urethral cancer
28. Non-Surgical Bladder-Sparing Multimodal Management in Organ-Confined Urothelial Carcinoma of the Urinary Bladder: A Population-Based Analysis
29. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy
30. The effect of race/ethnicity on cancer-specific mortality after trimodal therapy
31. Other‐cause mortality in incidental prostate cancer
32. Trimodal therapy effect on survival in urothelial vs non‐urothelial bladder cancer
33. Identifying low cancer‐specific mortality risk lymph node‐positive radical prostatectomy patients
34. Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology images
35. Perioperative complications and in-hospital mortality in radical cystectomy patients with heart-valve replacement
36. Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma
37. Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients
38. Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study
39. The Association between Urinary Diversion Type and Other-Cause Mortality in Radical Cystectomy Patients
40. Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical Prostatectomy
41. Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis
42. Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease
43. The effect of married status on cancer‐specific mortality in nonmetastatic pelvic liposarcoma patients according to sex
44. The effect of treatment intensification on other-cause mortality in clear-cell metastatic renal cell carcinoma patients
45. Differences in overall survival of penile cancer patients versus population‐based controls
46. Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non‐metastatic renal cell carcinoma: Systematic review and meta‐analysis
47. Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage Analyses
48. ASO Visual Abstract: Prognostic Significance of Pathological Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era
49. Characteristics of incidental prostate cancer in the United States
50. Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.